BioSkryb Genomics is revolutionizing the field of single-cell genomics with PTA (Primary Template-directed Amplification), the proprietary technology used in our whole-genome sequencing solution that enables accurate and reproducible whole genome amplification (WGA).
Our proprietary approach to low-input DNA and single-cell WGA accurately calls variants in genomes and reproducibly captures more than 95% of the genomes of single cells. This industry-leading performance is highly scalable, supporting applications in clinical, translational, and life sciences research. We believe every cell is unique, treatments should be too.
We would love to start a conversation - attend our presentations or schedule a meeting with us on our partner page!